Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 488-494

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Targeting Cell Death and Proliferation Receptors in Cancer)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2797-2798

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Death Receptors to Fight Cancer: From Biological Rational to Clinical Implementation

By  

Current Medicinal Chemistry, Vol. 17, Iss. 25, 2010-09 ,pp. : 2713-2728

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I.   Moase Elaine H.   Allen Theresa M.  

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite

Antisense oligodeoxynucleotide targeting HER2 mRNA sensitized docetaxel in breast cancer treatment

By Sun Junzhong   Xu Yin   Song Santai   Wu Zuze   Duan Haifeng  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 49, Iss. 11, 2011-11 ,pp. : 1167-1172

Informa Healthcare

Access to resources Recommend Favorite